Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

Reducing the burden of influenza disease requires improved vaccines, and a recombinant influenza vaccine may contribute to this public-health goal. This vaccine contains recombinant hemagglutinin (HA) proteins produced in a serum-free medium by expresSF+ cells. These cells contain recombinant…

from α1 via xlomafota.13 on Inoreader http://ift.tt/2rYiB1v
via IFTTT